Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RIZZO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.034
EU - Europa 3.917
AS - Asia 3.226
SA - Sud America 493
AF - Africa 108
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.944
SG - Singapore 1.175
RU - Federazione Russa 921
CN - Cina 889
IT - Italia 870
FI - Finlandia 534
DE - Germania 392
BR - Brasile 384
HK - Hong Kong 287
VN - Vietnam 271
UA - Ucraina 217
GB - Regno Unito 188
PL - Polonia 173
FR - Francia 154
IE - Irlanda 149
KR - Corea 121
JP - Giappone 105
IN - India 78
SE - Svezia 78
BD - Bangladesh 67
NL - Olanda 56
AU - Australia 47
CA - Canada 44
AR - Argentina 41
TR - Turchia 41
IQ - Iraq 37
RO - Romania 37
BE - Belgio 35
CI - Costa d'Avorio 30
AT - Austria 29
ES - Italia 29
MX - Messico 25
ZA - Sudafrica 20
IR - Iran 19
MA - Marocco 18
UZ - Uzbekistan 18
VE - Venezuela 16
ID - Indonesia 14
EC - Ecuador 12
CO - Colombia 11
KE - Kenya 10
MY - Malesia 10
PK - Pakistan 9
PT - Portogallo 9
CH - Svizzera 8
DK - Danimarca 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
LB - Libano 7
OM - Oman 7
PY - Paraguay 7
AZ - Azerbaigian 6
NP - Nepal 6
PE - Perù 6
SA - Arabia Saudita 6
UY - Uruguay 6
EU - Europa 5
IL - Israele 5
JO - Giordania 5
TN - Tunisia 5
TW - Taiwan 5
UG - Uganda 5
AL - Albania 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
BH - Bahrain 3
CR - Costa Rica 3
EG - Egitto 3
GE - Georgia 3
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
LT - Lituania 2
MK - Macedonia 2
NG - Nigeria 2
QA - Qatar 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GR - Grecia 1
Totale 16.816
Salva come PNG Salva come JPEG
Città #
Fairfield 1.351
Ashburn 1.086
Singapore 738
Woodbridge 623
Seattle 523
Chandler 522
Houston 487
Wilmington 469
Cambridge 406
Ann Arbor 391
San Jose 295
Hong Kong 282
Palermo 222
Moscow 178
Council Bluffs 149
Helsinki 148
Zgierz 145
Dublin 144
Beijing 142
Medford 124
Des Moines 122
Jacksonville 107
Los Angeles 105
New York 99
Nanjing 96
Altamura 94
Tokyo 92
Ho Chi Minh City 86
Dallas 84
Princeton 79
San Diego 79
The Dalles 79
Santa Clara 77
Lauterbourg 75
Lawrence 71
Dearborn 66
Hanoi 57
Frankfurt am Main 56
Hefei 52
São Paulo 47
Boardman 44
Buffalo 44
Seoul 43
Ludwigshafen am Rhein 41
London 39
Chicago 37
Jinan 36
Phoenix 36
Brussels 33
Milan 33
Tulsa 32
Seongnam 31
Shenyang 31
Tianjin 31
Abidjan 30
Rome 29
Hebei 28
Nanchang 28
Orem 28
Bremen 26
Panama City 25
Changsha 24
Warsaw 23
Amsterdam 22
Guangzhou 22
Kumar 21
Nuremberg 19
Da Nang 18
Kitzingen 18
Brooklyn 17
Munich 17
Denver 16
Izmir 16
Ningbo 16
Saint Petersburg 16
Atlanta 15
Berlin 15
Columbus 15
Jiaxing 15
Orange 15
San Paolo di Civitate 14
Shanghai 14
Tehran 14
Baghdad 13
Montreal 13
Sydney 13
Enschede 12
Ankara 11
Belo Horizonte 11
Fuzhou 11
Manchester 11
Pune 11
Vienna 11
Zhengzhou 11
Chennai 10
Johannesburg 10
Kilburn 10
Melbourne 10
Stockholm 10
Toronto 10
Totale 11.323
Salva come PNG Salva come JPEG
Nome #
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 341
EGFR inhibition in NSCLC: New findings…. and opened questions? 336
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 318
Male breast cancer. 302
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 299
Anti-endothelin drugs in solid tumors 296
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 289
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 286
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 285
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 282
A headlight on liquid biopsies: a challenging tool for breast cancer management 280
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 279
Breast cancer genome-wide association studies: there is strength in numbers 276
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 271
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 270
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 270
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 267
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 266
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 264
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 263
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 262
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 261
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 259
Nintedanib in NSCLC: Evidence to date and place in therapy 253
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 252
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 250
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 244
Monoclonal antibodies in gastrointestinal cancers 243
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 240
Biomarkers and efficacy: Are we nearly there yet? 238
EGFR genomic alterations in cancer: prognostic and predictive values 237
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 236
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 234
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) 233
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 229
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 226
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 225
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 223
Sex steroids, carcinogenesis, and cancer progression 219
HER2-positive male breast cancer: An update 218
Hereditary ovarian cancer 217
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 215
Gene signatures in CRC and liver metastasis 213
New molecular targets in bone metastases 210
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial. 207
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 207
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer 203
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy. 200
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 199
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 198
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 198
Bortezomib: a new pro-apoptotic agent in cancer treatment. 197
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 190
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? 190
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients 188
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 187
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 187
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 187
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 186
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 185
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients 183
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 182
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 172
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 166
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 165
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 162
Low dose splenic irradiation in myelofibrosis: outcomes and toxicity of three radiation schedule 157
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients 155
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 153
Could starvation minimize chemotherapy-induced toxicities? 149
Early stage nasal vestibule tumors: safety and efficacy of HDR brachyterapy in elderly patients 148
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway 145
Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness 142
La consulenza genetica in oncologia: implicazioni biomolecolari e cliniche. 138
"ONCOGENE ADDICTED SOLID TUMORS: BIOMARKERS PROGNOSTIC AND PREDICTIVE OF RESISTANCE OR SENSITIVITY TO MOLECULAR TARGETED THERAPIES IN CRC 138
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 137
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 134
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 99
Cardiovascular risk in patients without known cardiovascular disease 91
null 9
Totale 17.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 0 0 0 0 156 117
2021/20221.192 68 295 30 38 63 46 87 52 105 140 96 172
2022/20231.502 147 300 30 189 150 230 111 102 142 8 55 38
2023/2024616 30 81 50 37 36 110 73 78 2 15 12 92
2024/20251.593 30 108 97 126 55 67 162 151 86 166 197 348
2025/20265.510 464 171 306 439 566 792 830 669 485 531 257 0
Totale 17.311